RNXT Competitors & Alternatives

Compare RenovoRx Inc with similar stocks in the same industry

Biotechnology

RNXT

Main Stock
$1.25
Tradestie Score
29
Market Cap
$49.11M
Revenue Growth
1.2%
Analyst Upside
+460.0%

Top Competitors

242 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ANRO Alto Neuroscience Inc.
$36.25
$110.20M - 35 Compare
OVID Ovid Therapeutics Inc. Common Stock
$2.82
$97.42M - 45 Compare
PRLD Prelude Therapeutics Incorporated
$6.47
$85.47M - 36 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.42
$84.52M - 49 Compare
ARTV Artiva Biotherapeutics, Inc. Common Stock
$11.52
$71.32M - 47 Compare
ABVC ABVC BioPharma, Inc. Common Stock
$0.84
$70.39M - 57 Compare
IMMX Immix Biopharma, Inc. Common Stock
$13.61
$67.94M - 34 Compare
EVAX Evaxion A/S American Depositary Share
$3.40
$28.05M - 32 Compare
BFRI Biofrontera Inc. Common Stock
$1.46
$10.88M - 38 Compare
KTTA Pasithea Therapeutics Corp. Common Stock
$0.51
$5.73M - 32 Compare

Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)

242 stocks in this industry